Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors — Stella

Home/Participants With Advanced Solid Tumor Malignancies/

View on ClinicalTrials.gov

Recruiting

Back to Participants With Advanced Solid Tumor Malignancies trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality

Key details

Phase

Early testing / Safety & dosing

Sponsor

VelaVigo Bio Inc

Enrollment target

~255 participants

Started

December 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.